Using Guardant 360 ctDNA analysis, 78.6% of 220 patients with RCC had >1 alteration and the most frequent alterations were TP53 (35%), VHL (23%), EGFR (17%), NF1 (16%), and ARID1A (12%) [87]. The gene discussed is VHL; the disease is renal cell carcinoma.